Abstract
The diagnosis of breast cancer (BC) during pregnancy is uncommon. It has varied among
different studies from 1:10,000 to 1:3000 of all pregnancies, with a median age of
33 years. Pregnancy-associated BC represents a challenge in terms of clinical management
to guarantee both maternal and fetal security in choosing the right treatment. This
situation is complex and requires a multidisciplinary approach, including the surgeon,
anesthesiologist, oncologist, radiotherapist, psychologist, and maternal–fetal medicine
specialist. In the present review, we examined the management of pregnancy-associated
BC, focusing on pathophysiologic background, risk factors, diagnosis, staging procedures,
anesthesia, surgical management, and systemic treatment.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical Breast CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer statistics, 2018.CA Cancer J Clin. 2018; 68: 7-30
- Higher incidence of premenopausal breast cancer in less developed countries; myth or truth?.BMC Cancer. 2014; 14: 343
- Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study.J Clin Oncol. 2009; 27: 45-51
- Cancer and pregnancy: poena magna, not anymore.Eur J Cancer. 2006; 42: 126-140
- RCOG Green-top Guideline No. 12. Pregnancy and breast cancer. Royal College of Obstetricians and Gynaecologists; 2011.(Available at:) (Accessed: April 4, 2020)
- Epidemiology and pathophysiology of pregnancy-associated breast cancer: a review.Breast. 2017; 35: 136-141
- The impact of pregnancy on breast cancer outcomes in women < or = 35 years.Cancer. 2009; 115: 1174-1184
- Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects.Br J Cancer. 2005; 92: 167-175
- Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.Int J Cancer. 2005; 117: 988-991
- Gene expression patterns in the human breast after pregnancy.Cancer Prev Res (Phila). 2010; 3: 301-311
- High incidence of triple negative breast cancers following pregnancy and an associated gene expression signature.Springerplus. 2015; 4: 710
- Defining the genomic signature of the parous breast.BMC Med Genomics. 2012; 5: 1
- Pregnancy and breast cancer: when they collide.J Mammary Gland Biol Neoplasia. 2009; 14: 87-98
- Pregnancy-associated breast cancer and metastasis.Nat Rev Cancer. 2006; 6: 281-291
- Estrogen carcinogenesis in breast cancer.N Engl J Med. 2006; 354: 270-282
- A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.Cancer Res. 2003; 63: 8912-8921
- Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitro.Cancer Res. 1989; 4: 4765-4769
- Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers.Cancer Res. 2007; 67: 2062-2071
- Heightened risk of breast cancer following pregnancy: could lasting systemic immune alterations contribute?.Cancer Epidemiol Biomarkers Prev. 2007; 16: 1082-1086
- Apoptotic cell death and tissue remodelling during mouse mammary gland involution.Development. 1992; 115: 49-58
- Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways.Development. 1996; 122: 181-193
- Remodeling mechanisms of the mammary gland during involution.Int J Dev Biol. 2011; 55: 757-762
- Alternatively activated macrophages and collagen remodelling characterize the postpartum involuting mammary gland across species.Am J Pathol. 2010; 176: 1241-1255
- Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study.Ann Epidemiol. 2013; 23: 551-557
- Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers.Lancet. 1998; 352: 1359-1360
- Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2.Lancet. 1999; 354: 1846-1850
- Pregnancies, breast-feeding, and breast cancer risk in the international BRCA1/2 carrier cohort study (IBCCS).J Natl Cancer Inst. 2006; 98: 535-544
- Effect of parity and age at delivery on breast cancer risk in Slovenian women aged 25-54 years.Int J Cancer. 1997; 73: 1-9
- Clinicopathologic characteristics of pregnancy-associated breast cancer: results of analysis of a nationwide breast cancer registry database.J Breast Cancer. 2017; 20: 264-269
- Reproductive risk factors in relation to molecular subtypes of breast cancer: results from the nurses' health studies.Int J Cancer. 2016; 138: 2346-2356
- Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer.Breast Cancer Res Treat. 2012; 131: 159-167
- Epidemiology of basal-like breast cancer.Breast Cancer Res Treat. 2008; 109: 123-139
- Differences in risk factors for breast cancer molecular subtypes in a population-based study.Cancer Epidemiol Biomark Prev. 2007; 16: 439-443
- Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.Breast Cancer Res Treat. 2013; 137: 579-587
- Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.Cancer Causes Control. 2011; 22: 399-405
- Important role of menarche in development of estrogen receptor-negative breast cancer in African American women.J Natl Cancer Inst. 2015; 107: djv172
- Breastfeeding and maternal health outcomes: a systematic review and meta-analysis.Acta Paediatr. 2015; 104: 96-113
- Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.Lancet. 2002; 360: 187-195
- The protective effect of longer duration of breastfeeding against pregnancy-associated triple negative breast cancer.Oncotarget. 2016; 7: 53941-53950
- Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group.Int J Cancer. 1997; 72: 720-727
- Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer.Cancer. 2012; 118: 3254-3259
- Pregnancy-associated breast cancers: do they differ from other breast cancers in young women?.Breast. 2012; 21: 550-555
- Clinicopathological features and prognosis of pregnancy associated breast cancer—a matched case control study.Pathol Oncol Res. 2014; 20: 581-590
- Biology of breast cancer during pregnancy using genomic profiling.Endocr Relat Cancer. 2014; 21: 545-554
- RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.Breast Cancer Res. 2015; 17: 24
- Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy.Breast. 2015; 24: 290-293
- Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression.Int J Biol Sci. 2010; 6: 428-442
- Breast cancer in pregnancy: a literature review.Arch Surg. 2003; 138: 91-99
- Breast cancer diagnosis during pregnancy.Womens Health (Lond Engl). 2009; 5: 243-249
- Accuracy of diagnostic mammography and breast ultrasound during pregnancy and lactation.AJR Am J Roentgenol. 2011; 196: 716-722
- Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy.Radiology. 2006; 239: 52-60
- Management of breast cancer during pregnancy.Obstet Gynecol. 2010; 12: 186-192
- The 2007 recommendations of the International Commission on Radiological Protection.Ann ICRP. 2007; 37: 1-332
- Breast imaging of the pregnant and lactating patient: physiologic changes and common benign entities.AJR Am J Roentgenol. 2013; 200: 329-336
- Breast cancer during pregnancy.Eur J Obstet Gynecol Reprod Biol. 2009; 147: 9-14
- Breast cancer in pregnancy.Breast J. 2010; 16: S22-S25
- Foetal risk in diagnostic radiology.Semin Ultrasound CT MR. 2012; 33: 4-10
- ACR Manual on Contrast Media.(Available at:) (Accessed: April 4, 2020)
- NCCN Guidelines, version 1.2018: Breast Cancer.(Available at:) (Accessed: April 4, 2020)
- Respiratory physiology in pregnancy.Clin Chest Med. 2011; 32: 1-13
- Anesthesia-related maternal mortality in the United States: 1979-2002.Obstet Gynecol. 2011; 117: 69-74
- Cardiac surgery during pregnancy.J Heart Valve Dis. 2006; 15: 686-690
- Hypercoagulable states.Crit Care Clin. 2011; 27: 933-952
- Gastric emptying of water in obese pregnant women at term.Anesth Analg. 2007; 105: 751-755
- Oral clefts and diazepam use during pregnancy.N Engl J Med. 1984; 311: 919-920
- The effects of benzodiazepine use during pregnancy and lactation.Reprod Toxicol. 1994; 8: 461-475
- Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2013; 24: vi60-vi70
- Locoregional treatment of breast cancer during pregnancy.Gynecol Surg. 2014; 11: 279-284
- Safety of sentinel node biopsy in pregnant patients with breast cancer.Ann Oncol. 2004; 15: 1348-1351
- Sentinel lymph node biopsy in pregnant patients with breast cancer.Eur J Nucl Med Mol Imaging. 2010; 37: 78-93
- Sentinel lymph node biopsy during pregnancy: initial clinical experience.Ann Surg Oncol. 2007; 14: 218-221
- Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy.Ann Surg Oncol. 2009; 16: 1143-1147
- Principles and controversies in lymphoscintigraphy with emphasis on breast cancer.Surg Clin North Am. 2000; 80: 1721-1739
- The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid.Breast J. 2004; 10: 492-495
- Breast cancer and pregnancy: diagnosis and treatment options.Breast Cancer Online. 2009; 12: e10
- Pharmacokinetics of methylene blue dye for lymphatic mapping in breast cancer—implications for use in pregnancy.Am J Surg. 2011; 201: 70-75
- Immediate breast reconstruction with expander in pregnant breast cancer patients.Breast. 2013; 22: 657-660
- Immediate breast reconstruction following mastectomy in pregnant women with breast cancer.J Surg Oncol. 2016; 114: 140-143
- Breast reconstruction in pregnancy: a case report of multidisciplinary team approach in immediate autologous flap reconstruction for pregnancy-associated breast cancer.Clin Case Rep. 2017; 5: 1450-1453
- Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study.J Clin Oncol. 2013; 31: 2532-2539
- 5-Year overall survival after early breast cancer diagnosed during pregnancy: a retrospective case-control multicentre French study.Eur J Cancer. 2018; 95: 30-37
- Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients.JAMA Oncol. 2015; 1: 1145-1153
- Combined chemotherapy and teratogenicity.Birth Defects Res Part A Clin Mol Teratol. 2005; 73: 634-637
- Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.J Clin Oncol. 2005; 23: 4192-4197
- Birth defects: data and statistics.(Available at:)http://www.cdc.gov/ncbddd/birthdefects/data.htmlDate accessed: July 23, 2018
- Treatment of breast cancer during pregnancy: regimen selection, pregnancy monitoring and more.Breast. 2011; 20: 1-6
- Breast cancer during pregnancy: maternal and foetal outcomes.Cancer J. 2010; 16: 76-82
- Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.Cancer. 2006; 107: 1219-1226
- Treatment of breast cancer during pregnancy: an observational study.Lancet Oncol. 2012; 13: 887-896
- Weekly epirubicin in the treatment of gestational breast cancer (GBC).Breast Cancer Res Treat. 2009; 115: 591-594
- Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences.Cancer Biol Med. 2018; 15: 6-13
- Taxanes for breast cancer during pregnancy: a systematic review.Ann Oncol. 2010; 21: 425-426
- Taxanes for breast cancer during pregnancy: a systematic review.Clin Breast Cancer. 2013; 13: 16-23
- Maternal and foetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature.Ann Oncol. 2012; 23: 3016-3023
- Long-term follow-up of the E1199 phase III trial evaluating the role of taxane and schedule in operable breast cancer.J Clin Oncol. 2015; 33: 2353-2360
- Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes.J Clin Oncol. 2010; 28: 683-689
- Trastuzumab containing regimens for early breast cancer.Cochrane Database Syst Rev. 2012; 4: CD006243
- Requirement for neuregulin receptor erbB2 in neural and cardiac development.Nature. 1995; 378: 394-398
- Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge.Exp Rev Clin Immunol. 2010; 6: 821-826
- Multidisciplinary management of breast cancer during pregnancy.Oncologist. 2017; 22: 324-334
- Goldenhar's syndrome associated with tamoxifen given to the mother during gestation.JAMA. 1994; 271: 1905-1906
- Tamoxifen as systemic treatment of advanced breast cancer during pregnancy—case report and literature review.Gynecol Oncol. 2001; 80: 405-408
- Use of tamoxifen before and during pregnancy.Oncologist. 2011; 16: 1547-1551
- The use of bisphosphonates in women prior to or during pregnancy and lactation.Hormones (Athens). 2011; 10: 280-291
- 5-HT3 receptor antagonists for the treatment of nausea/vomiting.Ann Palliat Med. 2012; 1: 115-120
- A randomized pilot trial of administration of granulocyte colony-stimulating factor to women before preterm delivery.Am J Obstet Gynecol. 1998; 179: 766-771
- Lack of permeability of the human placenta for erythropoietin.J Perinat Med. 1995; 23: 71-76
- Increasing use of antibiotics in pregnancy during the period 2000-2010: prevalence, timing, category, and demographics.BJOG. 2014; 121: 988-996
- Risk factors: after gestational chemotherapy, the kids are all right.Nat Rev Clin Oncol. 2015; 12: 254-255
- Persistent parity-induced changes in growth factors, TGF-b3, and differentiation in the rodent mammary gland.Mol Endocrinol. 2002; 16: 2034-2051
- Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations.Breast Cancer. 2018; 23: 1-7
Article info
Publication history
Published online: July 19, 2020
Accepted:
July 14,
2020
Received in revised form:
July 7,
2020
Received:
April 6,
2020
Footnotes
I.P., D.D.G. and L.C. share first co-authorship.
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
